English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [9503]
News [23297]
Articles [1985]
Editorials [134]
Conferences [463]
elearning [298]
AI cancer tools risk “shortcut learning” rather than detecting true biology
AI cancer tools risk “shortcut learning” rather than detecting true biology
ASCO GU 2026: Belzutifan plus pembrolizumab post-surgery helps ccRCC patients at high risk for relapse stay cancer-free longer
ASCO GU 2026: Belzutifan plus pembrolizumab post-surgery helps ccRCC patients at high risk for relapse stay cancer...
ASCO GU 2026: Combo targeting blood vessel growth controls ccRCC better than single agent
ASCO GU 2026: Combo targeting blood vessel growth controls ccRCC better than single agent
ASCO GU 2026: Blood test predicts which bladder cancer patients may safely skip surgery
ASCO GU 2026: Blood test predicts which bladder cancer patients may safely skip surgery
Hypertension treatment linked to lower mortality for patients with metastatic breast cancer
Hypertension treatment linked to lower mortality for patients with metastatic breast cancer
Immune cells link lactation to long-lasting health
Immune cells link lactation to long-lasting health
ASCO GU 2026: Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery
ASCO GU 2026: Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery
Fifteen-year results from SWOG S0016 trial suggest follicular lymphoma is curable
Fifteen-year results from SWOG S0016 trial suggest follicular lymphoma is curable
ASCO GU 2026: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer
ASCO GU 2026: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic...
FDA grants accelerated approval to zongertinib for unresectable or metastatic non-squamous non-small cell lung cancer
FDA grants accelerated approval to zongertinib for unresectable or metastatic non-squamous non-small cell lung...
<1…1112131415…2330>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top